Lundbeck pens $2B Alder takeover to boost brain disease pipeline

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Sep 16, 2019 at 9:32 AM.

  1. #1 cafead, Sep 16, 2019 at 9:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,973
    Likes Received:
    3
    via Lundbeck has struck a deal to buy Alder BioPharmaceuticals for almost $2 billion. The takeover centers on a near-approval anti-CGRP antibody that could address Lundbeck’s need for revenue drivers to mitigate the loss of patent protection on Northera.

    article source
     
    Quote

Reply to Thread